349 related articles for article (PubMed ID: 28282033)
1. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
[TBL] [Abstract][Full Text] [Related]
2. Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
Pillinger G; Loughran NV; Piddock RE; Shafat MS; Zaitseva L; Abdul-Aziz A; Lawes MJ; Bowles KM; Rushworth SA
Oncotarget; 2016 Jun; 7(26):39784-39795. PubMed ID: 27174919
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.
Ali AY; Wu X; Eissa N; Hou S; Ghia JE; Murooka TT; Banerji V; Johnston JB; Lin F; Gibson SB; Marshall AJ
Leukemia; 2018 Sep; 32(9):1958-1969. PubMed ID: 29479062
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.
Zhang Z; Liu J; Wang Y; Tan X; Zhao W; Xing X; Qiu Y; Wang R; Jin M; Fan G; Zhang P; Zhong Y; Kong D
FASEB J; 2018 Nov; 32(11):5967-5975. PubMed ID: 29792732
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.
Ma CC; Zhang CM; Tang LQ; Liu ZP
Eur J Med Chem; 2018 May; 151():9-17. PubMed ID: 29601991
[TBL] [Abstract][Full Text] [Related]
6. p84 forms a negative regulatory complex with p110γ to control PI3Kγ signalling during cell migration.
Turvey ME; Klingler-Hoffmann M; Hoffmann P; McColl SR
Immunol Cell Biol; 2015 Sep; 93(8):735-43. PubMed ID: 25753393
[TBL] [Abstract][Full Text] [Related]
7. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
Juss JK; Hayhoe RP; Owen CE; Bruce I; Walmsley SR; Cowburn AS; Kulkarni S; Boyle KB; Stephens L; Hawkins PT; Chilvers ER; Condliffe AM
PLoS One; 2012; 7(9):e45933. PubMed ID: 23029326
[TBL] [Abstract][Full Text] [Related]
8. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammation effects of naloxone involve phosphoinositide 3-kinase delta and gamma.
Wang TY; Su NY; Shih PC; Tsai PS; Huang CJ
J Surg Res; 2014 Dec; 192(2):599-606. PubMed ID: 25016442
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of PI3Kδ and PI3Kγ in a toluene diisocyanate-induced murine asthma model.
Xu C; Chen S; Deng Y; Song J; Li J; Chen X; Chang P; Yao L; Tang H
Toxicology; 2021 Apr; 454():152747. PubMed ID: 33711354
[TBL] [Abstract][Full Text] [Related]
11. Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
Stark AK; Davenport ECM; Patton DT; Scudamore CL; Vanhaesebroeck B; Veldhoen M; Garden OA; Okkenhaug K
J Immunol; 2020 Jul; 205(1):78-89. PubMed ID: 32414808
[TBL] [Abstract][Full Text] [Related]
12. Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib.
Till KJ; Abdullah M; Alnassfan T; Janet GZ; Marks T; Coma S; Weaver DT; Pachter JA; Pettitt AR; Slupsky JR
Sci Rep; 2023 Mar; 13(1):3793. PubMed ID: 36882482
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.
Uehara M; McGrath MM; Ohori S; Solhjou Z; Banouni N; Routray S; Evans C; DiNitto JP; Elkhal A; Turka LA; Strom TB; Tullius SG; Winkler DG; Azzi J; Abdi R
Nat Commun; 2017 Oct; 8(1):951. PubMed ID: 29038423
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
15. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
[TBL] [Abstract][Full Text] [Related]
16. High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib.
Malek E; Driscoll JJ
Oncotarget; 2016 Jun; 7(25):38523-38538. PubMed ID: 27229530
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
[TBL] [Abstract][Full Text] [Related]
18. PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Funk CR; Wang S; Chen KZ; Waller A; Sharma A; Edgar CL; Gupta VA; Chandrakasan S; Zoine JT; Fedanov A; Raikar SS; Koff JL; Flowers CR; Coma S; Pachter JA; Ravindranathan S; Spencer HT; Shanmugam M; Waller EK
Blood; 2022 Jan; 139(4):523-537. PubMed ID: 35084470
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase β, phosphoinositide 3-kinase δ, and phosphoinositide 3-kinase γ mediate the anti-inflammatory effects of magnesium sulfate.
Lee PY; Yang CH; Kao MC; Su NY; Tsai PS; Huang CJ
J Surg Res; 2015 Aug; 197(2):390-7. PubMed ID: 25972311
[TBL] [Abstract][Full Text] [Related]
20. Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
Perry MWD; Abdulai R; Mogemark M; Petersen J; Thomas MJ; Valastro B; Westin Eriksson A
J Med Chem; 2019 May; 62(10):4783-4814. PubMed ID: 30582813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
